Epigral is planning to establish a new manufacturing facility for Epoxy Resin & Formulations and Multi-Purpose Plant (MPP) at its existing facility at Dahej, Gujarat, as part of the company's strategic growth and expansion initiatives. The project entails an estimated investment of Rs 600 crore, with both facilities expected to be commissioned in the second half of FY28.
Epigral is primarily engaged in manufacturing and selling of Chlor Alkali & its Derivatives. The Company is also engaged in Trading of Agrochemical products.
